Your email has been successfully added to our mailing list.

×
0.00786529300985931 0.00803146117203941 0.0191647280381079 0.0247036667774454 0.0247036667774454 0.0136257892987703 0.0108563199291016 0.0191647280381079
Stock impact report

Aralez Pharmaceuticals: Oversold And Undervalued [Seeking Alpha]

ARALEZ PHARMACEUTICALS INC COMMON SHARES (ARLZ) 
Last aralez pharmaceuticals inc common shares earnings: 5/8 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: aralez.com/investors
Company Research Source: Seeking Alpha
Aralez Pharmaceuticals: Oversold And UndervaluedSummaryQ4 2017 and full year 2017 earnings released on March 13, 2018.Q4 net revenues of $28 million and 2017 full year net revenues of $105.9 million exceeded guidance.2018 financial guidance reaffirmed: $140-160 million net revenues with projected adjusted EBITDA of between $35 million and $55 million.Announced discontinuation of Yosprala in the U.S.With a market cap of only $116 million, Aralez's shares are oversold and undervalued following the recent market sell-off following the Q4 earnings release. Show less Read more
Impact Snapshot
Event Time:
ARLZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ARLZ alerts
Opt-in for
ARLZ alerts

from News Quantified
Opt-in for
ARLZ alerts

from News Quantified